| Changes in positive and negative affect during pharmacological treatment and cognitive therapy for major depressive disorder: A secondary analysis of two randomized controlled … BD Dunn, RE German, G Khazanov, C Xu, SD Hollon, RJ DeRubeis Clinical Psychological Science 8 (1), 36-51, 2020 | 83 | 2020 |
| Prevention of recurrence after recovery from a major depressive episode with antidepressant medication alone or in combination with cognitive behavioral therapy: phase 2 of a 2 … RJ DeRubeis, J Zajecka, RC Shelton, JD Amsterdam, J Fawcett, C Xu, ... JAMA psychiatry 77 (3), 237-245, 2020 | 57 | 2020 |
| Distress and anhedonia as predictors of depression treatment outcome: A secondary analysis of a randomized clinical trial GK Khazanov, C Xu, BD Dunn, ZD Cohen, RJ DeRubeis, SD Hollon Behaviour Research and Therapy 125, 103507, 2020 | 44 | 2020 |
| Relative effectiveness of tricyclic antidepressant versus monoamine oxidase inhibitor monotherapy for treatment-resistant depression T Kim, C Xu, JD Amsterdam Journal of Affective Disorders 250, 199-203, 2019 | 29 | 2019 |
| Predictive modeling for response to lithium and quetiapine in bipolar disorder TT Kim, S Dufour, C Xu, ZD Cohen, L Sylvia, T Deckersbach, ... Bipolar Disorders 21 (5), 428-436, 2019 | 22 | 2019 |
| Research in clinical psychology: Social exclusion and psychological disorders K Fung, C Xu, BL Glazier, CA Parsons, LE Alden Social exclusion: Psychological approaches to understanding and reducing its …, 2016 | 21 | 2016 |
| Adding cognitive therapy to antidepressant medications decreases suicidal ideation GK Khazanov, C Xu, SD Hollon, RJ DeRubeis, ME Thase Journal of affective disorders 281, 183-191, 2021 | 12 | 2021 |
| What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of … HE Pigott, T Kim, C Xu, I Kirsch, J Amsterdam BMJ open 13 (7), e063095, 2023 | 7 | 2023 |
| A comparison of prolonged exposure therapy, pharmacotherapy, and their combination for PTSD: What works best and for whom; study protocol for a randomized trial K Bredemeier, S Larsen, G Shivakumar, K Grubbs, C McLean, C Tress, ... Contemporary Clinical Trials 119, 106850, 2022 | 5 | 2022 |
| Multi‐trial, aggregated, individual participant data mega‐analysis of short‐term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episode JD Amsterdam, C Xu Bipolar Disorders, 2023 | 3 | 2023 |
| Urbanicity and depression: A global meta-analysis C Xu, L Miao, D Turner, R DeRubeis Journal of Affective Disorders, 2023 | 3 | 2023 |
| Emotion regulation strategy correlates with discrete state emotion in major depression C Xu, H Gelberg, RJ DeRubeis Anxiety, Stress, & Coping 35 (6), 637-648, 2022 | 3 | 2022 |
| Patients’ judgments of the importance of treatment-induced reductions in symptoms of depression: The role of specific symptoms, magnitudes of change, and post-treatment levels TT Kim, C Xu, RJ Derubeis Psychotherapy research 32 (3), 404-413, 2022 | 2 | 2022 |
| Mapping Female Patients’ Judgments of Satisfaction to Hypothetical Changes in Depression Symptom Severity TT Kim, C Xu, RJ DeRubeis Behavior Therapy 53 (2), 392-399, 2022 | | 2022 |
| Applications of Advanced Statistical Modeling Techniques for Understanding Depression C Xu University of Pennsylvania, 2022 | | 2022 |
